BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BPI Events About Subscribe Contribute

Upstream

Recent in Upstream

See all

Croda Pharma Ask the Expert

Sponsored Content

Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency

byBPI Contributor

Oct 29, 2024

1 Hr View

Sartorius

Sponsored Content

Building Reliability Into Scale-Up: Targeted Optimization for AAV Production Building Reliability Into Scale-Up: Targeted Optimization for AAV Production

byBPI Contributor

Sep 17, 2024

40 Min View

Downstream

Recent in Downstream

See all

Saint Gobain Life Sciences filtration

Sponsored Content

Filter Integrity Uncovered: Techniques and Best Practices Filter Integrity Uncovered: Techniques and Best Practices

byBPI Contributor

Dec 3, 2024

30 Min View

Bio-Rad Ask the Expert webcast

Sponsored Content

Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges

byBPI Contributor

Nov 14, 2024

15 Min View

Manufacturing

Recent in Manufacturing

See all

908 Devices Ask the Expert

Sponsored Content

Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality

byBPI Contributor

Nov 19, 2024

30 Min View

Lonza Ask the Expert

Sponsored Content

Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System

byBPI Contributor

Oct 31, 2024

50 Min View

Analytical

Recent in Analytical

See all

ValGenesis Ask the Expert webinar

Sponsored Content

Out of the Box Computer Software Assurance with ValGenesis VLMS Out of the Box Computer Software Assurance with ValGenesis VLMS

byBPI Contributor

Nov 7, 2024

30 Min View

Samsung S-Tesify

Sponsored Content

Innovative Approaches to Enhance Cell Culture Density for High-Quality Production Innovative Approaches to Enhance Cell Culture Density for High-Quality Production

byBPI Contributor

Sep 19, 2024

15 Min View

Business

Recent in Business

See all

Scorpius BioManufacturing Ask the Expert webcast

Sponsored Content

An Innovative Funding Model for Biotech Companies An Innovative Funding Model for Biotech Companies

byBPI Contributor

Dec 10, 2024

7 Min View

Lonza Ask the Expert webcast

Sponsored Content

Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality

byBPI Contributor

Nov 21, 2024

30 Min View

Therapeutic Modalities

Recent in Therapeutic Modalities

See all

Roche ATE webinar

Sponsored Content

Decoding AAV Manufacturing: Navigating Critical Quality Attributes and their Analytics Decoding AAV Manufacturing: Navigating Critical Quality Attributes and their Analytics

byBPI Contributor

Oct 11, 2024

20 Min View

thumbnail

Bioprocess Insider

Biomanufacturing in space accelerating therapy development on Earth Biomanufacturing in space accelerating therapy development on Earth

byJosh Abbott

Jul 24, 2024

3 Min Read

BioProcess Insider

Recent in BioProcess Insider

See all

thumbnail

Facilities & Capacity

Lonza calls time on capsules as mAbs and CGT drive core CDMO strategy Lonza calls time on capsules as mAbs and CGT drive core CDMO strategy

byDan Stanton

Dec 16, 2024

3 Min Read

Sartorius CGT newsletter

Sponsored Content

Setting the Standard in Cell and Gene Therapy: Perspectives on Performance, Scalability, and Regulatory Compliance Setting the Standard in Cell and Gene Therapy: Perspectives on Performance, Scalability, and Regulatory Compliance

byBPI Contributor

Dec 4, 2024

2 Min Read

Sponsored Content

Are You Into Biosimilars?

BPI Contributor

May 1, 2013

1 Min Read

Already have an account?

Sponsored Content

Learn about GE Healthcare Life Sciences’ aim to help bioprocessing teams map out the optimal plan to transform a biosimilars project idea into result, with greater flexibility and confidence and with reduced time and cost.

About the Author

BPI Contributor

See more from BPI Contributor

Webinars

Ask the Expert webcasts

ATE Webcasts

Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™

Sponsored Content

Special Report

From Pipettes to Infusion Pumps: Volume Accuracy in Regulated Industries and Its Critical Impact

Insider News

SK pharmteco secures $1.4bn GLP-1 deal
Dec 19, 2024
|
2 Min Read
MilliporeSigma to acquire Netherlands-based organoid pioneer HUB
Dec 18, 2024
|
2 Min Read
Israeli biomanufacturer Scinai expands into US with CDMO subsidiary
Dec 18, 2024
|
2 Min Read
CGT Catapult and UCL to develop digital twin for CAR-T manufacturing
Dec 17, 2024
|
3 Min Read

See all

Exosomes Europe

Jun 5 - Jun 6, 2024

Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization

Learn More